In spiking experiments, using various dilutions of prostate cancer cells in blood from the same donors, we successfully detected prostate-specific mRNAs, the AR-V7 splice variant, as well as the c.2632A > G; p.T878A mutation in LNCaP-spiked blood (see Supplementary Methods). This evidence concerns the gene AR and prostate cancer.